Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes

NCT01045447 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

465

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: insulin degludec/insulin aspart
DRUG: insulin glargine

Sponsor

Novo Nordisk A/S